Fluorinated Pyrazole–Bpin Building Block: The Molecular Design Logic Behind 3-Fluoropyrazole-4-boronic Acid Pinacol Ester
Fluorinated Pyrazole–Bpin Building Block: The Molecular Design Logic Behind 3-Fluoropyrazole-4-boronic Acid Pinacol Ester
1. Understanding the Design Value of Fluorinated Heteroaromatic Rings Through a Small Building Block
In small-molecule drug discovery, the value of a molecular building block depends not only on whether its structure is novel, but also on whether it can be effectively introduced into target molecules and provide well-defined variables for structural optimization.
3-Fluoropyrazole-4-boronic acid pinacol ester, also known as 3-Fluoropyrazole-4-boronic Acid Pinacol Ester, CAS No. 1983153-03-2, has a relatively simple structure, but it contains two key design elements: a fluorinated pyrazole fragment and a Bpin functionality.
Bpin usually refers to a boronic acid pinacol ester group in the form of –B(pin), namely a pinacol boronate / pinacolato boryl fragment. In medicinal chemistry and organic synthesis, this type of organoboron compound is commonly used as the organoboron coupling partner in Suzuki-Miyaura cross-coupling reactions.

From a structural perspective, this building block can be divided into three key parts:
Structural Region | Structural Feature | Molecular Design Significance |
Pyrazole ring | Five-membered nitrogen-containing heteroaromatic ring with two nitrogen atoms | Affects hydrogen-bonding interactions, polarity, electronic distribution, and binding orientation |
3-Fluoro substitution | Introduction of a fluorine atom at the 3-position of the pyrazole ring | Provides variables for electronic effects, steric effects, and local property modulation |
4-Bpin site | Boronic acid pinacol ester attached at the 4-position of the pyrazole ring | Serves as a coupling interface for constructing carbon-carbon bonds and connecting to complex molecular scaffolds |
2. Why Drug Molecule Optimization Needs This Type of Structure
2.1 Drug Optimization Requires Controllable Structural Variables
Lead compound optimization is usually carried out around a series of specific issues:
Optimization Challenge | Requirement for Structural Design |
Insufficient potency | Interactions with key regions of the target need to be adjusted |
Insufficient selectivity | The local structure needs to be changed so that it better fits the target protein rather than related targets |
Unsatisfactory physicochemical properties | Polarity, lipophilicity, acidity/basicity, or conformational features need to be adjusted |
Insufficient metabolic stability | Metabolically labile sites need to be identified and modified |
Unclear SAR interpretation | A single variable needs to be introduced to reduce interference caused by excessive structural changes |
SAR is the abbreviation for Structure-Activity Relationship, referring to the relationship between changes in molecular structure and changes in biological activity. SAR studies emphasize “controlled structural modification” rather than the random accumulation of different fragments.
2.2 High-Value Building Blocks Usually Have Two Capabilities
Useful building blocks in drug discovery often possess two types of capabilities at the same time:
Capability | Specific Meaning | Corresponding Role of 3-Fluoropyrazole-4-boronic Ester |
Medicinal chemistry modulation capability | After introduction, it may alter binding, electronic properties, polarity, conformation, or metabolic characteristics | Provided by the 3-fluoropyrazole fragment |
Synthetic connection capability | It can be incorporated into complex structures through reliable reactions | Provided by the Bpin site |
3. Fluorinated Pyrazole: Not Just a Simple Heterocycle, but a Local Property-Modulating Unit
3.1 Core Role of the Pyrazole Ring: Providing Recognition Features of a Nitrogen-Containing Heteroaromatic Ring
Pyrazole is a five-membered nitrogen-containing heteroaromatic ring containing two nitrogen atoms. Compared with ordinary carbocyclic rings, a pyrazole ring can change a molecule’s hydrogen-bonding capability, dipole moment, electronic distribution, and local polarity. In drug molecules, pyrazole fragments often play the following roles:
Role Type | Specific Significance |
Participation in hydrogen bonding | Pyrazole nitrogen atoms may act as hydrogen-bond acceptors or participate in specific binding networks. In an unsubstituted N-H pyrazole, the N-H may act as a hydrogen-bond donor, while the pyridine-type nitrogen may act as a hydrogen-bond acceptor; after N-substitution, the hydrogen-bonding pattern changes accordingly |
Polarity modulation | Introduces nitrogen-containing heteroaromatic character and changes the overall or local polarity of the molecule |
Electronic modulation | Influences the electronic distribution of adjacent substituents and aromatic/heteroaromatic systems |
Structural replacement | Can be used as a replacement fragment for benzene, imidazole, triazole, or other heteroaromatic rings in SAR comparisons |
In the design of small-molecule drugs such as kinase inhibitors, heteroaromatic rings are often used to modulate interactions with residues near the ATP-binding site. The value of a pyrazole fragment lies in its ability to provide tunable structural variables for binding mode and physicochemical properties.
3.2 Significance of 3-Position Fluorination: Using a Small Atom to Produce Fine Effects
Fluorine has a special role in medicinal chemistry. It has a small atomic radius, strong electronegativity, and a stable C-F bond, and is often used to regulate electronic properties, acidity/basicity, metabolic stability, lipophilicity, and conformational preferences. In a 3-fluoropyrazole structure, the fluorine atom is located at the 3-position of the pyrazole ring, and its significance is mainly reflected in three aspects:
Design Aspect | Possible Effect |
Electronic effect | The strong electron-withdrawing character of fluorine may alter the electronic distribution of the pyrazole ring |
Steric effect | Fluorine is small in size and can introduce a substituent effect without significantly increasing steric burden |
Property modulation | May affect local polarity, pKa, binding orientation, and metabolic stability |
It should be noted that fluorination does not necessarily lead to improved activity. Its role is to provide a highly sensitive means of structural modulation. The actual outcome depends on the overall molecular structure, the target binding pocket, and neighboring functional groups. When researchers aim to tune the electronic properties, binding orientation, or local physicochemical properties of a heteroaromatic ring with minimal spatial change, 3-fluoropyrazole can serve as a valuable candidate fragment.
3.3 Structural Focus of 3-Fluoropyrazole: The Combined Role of Fluorine, Nitrogen, and the Connection Site
The following analysis uses the 1H-pyrazole representation as an example. In actual molecules, tautomerism of the unsubstituted N-H pyrazole and subsequent N-substitution may affect its hydrogen-bonding pattern and binding orientation.
Position | Structural Feature | Design Significance |
1-position N-H | Pyrazole N-H structure | May affect hydrogen-bonding pattern, tautomerism, and subsequent substitution design |
2-position pyridine-type nitrogen | Heterocyclic nitrogen containing a lone pair | May participate as a hydrogen-bond acceptor or regulate the electronic properties of the ring |
3-position F | Fluoro substitution | Provides electronic and steric fine-tuning |
4-position Bpin | Coupling-capable site | Determines whether the fragment can be incorporated into complex molecular scaffolds |
These structural points together determine its value.
If only the 3-fluoropyrazole is considered, it is a medicinal chemistry fragment.
If only Bpin is considered, it is a synthetic connection group.
When 3-fluoropyrazole and 4-Bpin are connected within the same molecule, the compound becomes a functionalized building block that can be used for molecular construction and structural optimization.
4. Bpin: A Connection Interface That Turns Structural Concepts into Synthesizable Molecules
4.1 The Essence of Bpin as an Organoboron Coupling Unit
Bpin, namely a boronic acid pinacol ester, is a common form of organoboron compound. Compared with free boronic acids, boronic acid pinacol esters generally offer better handling properties and stability, and are therefore commonly used as organoboron components in Suzuki-Miyaura coupling reactions.
Suzuki-Miyaura coupling reactions are commonly used to construct aryl-aryl, aryl-heteroaryl, or heteroaryl-heteroaryl carbon-carbon bonds. The general logic can be summarized as follows:
Reaction Component | Role |
Organoboron reagent | Provides an aryl or heteroaryl fragment |
Aryl/heteroaryl halide or related substrate | Provides another coupling-capable structure |
Palladium catalyst and base | Promote carbon-carbon bond formation |
Product | Two fragments are connected through a newly formed C-C bond |
4.2 How the Bpin Site Supports Incorporation of the Fluorinated Pyrazole Fragment into Complex Scaffolds
For drug molecule design, the value of Bpin is not merely that it is a functional group capable of participating in reactions. More importantly, it provides the ability to expand molecular structures. If a target molecule contains a coupling-capable aryl or heteroaryl halide site, 3-fluoropyrazole-4-boronic ester can be introduced as a fragment to construct new structures bearing a 3-fluoropyrazole substituent. This design strategy offers three practical advantages:
Advantage | Significance for Drug Discovery |
Concentrated structural change | Facilitates comparison of SAR differences before and after introduction of the 3-fluoropyrazole fragment |
Relatively clear synthetic route | Suzuki-Miyaura coupling is a commonly used method for introducing heteroaryl fragments, although specific conditions need to be optimized according to the substrate and protecting groups |
Convenient expansion of molecular libraries | Enables rapid preparation of a set of analogues around the same core scaffold |
4.3 The Combined Relationship Between 4-Bpin and 3-Fluoro Substitution
The structural design of 3-fluoropyrazole-4-boronic ester is not simply the addition of two functional groups. The 3-fluoro substituent and the 4-Bpin site perform clearly defined roles on the same pyrazole ring:
Structural Unit | Function |
3-position fluorine | Introduces electronic effects and local property-modulating variables |
Pyrazole ring | Provides recognition features of a nitrogen-containing heteroaromatic ring |
4-position Bpin | Provides an entry point for carbon-carbon bond construction |
The result of this combination is that a small molecular building block has both “tunability” and “connectability.” This is why, compared with an unfunctionalized pyrazole fragment, it is more suitable as a coupling-capable building block for analogue construction and SAR studies. Ordinary fragments that lack a usable connection site often require additional route design, whereas a Bpin-functionalized fluorinated pyrazole fragment can participate more directly in structural construction.
4.4 3-Fluoropyrazole-4-boronic Ester Is Suitable for the Following Design Questions:
Design Question | How This Building Block Helps |
Is it necessary to introduce a fluorinated heteroaromatic ring? | Provides the 3-fluoropyrazole fragment as a defined variable |
Is a certain site on the core scaffold suitable for connection to a heteroaromatic ring? | Enables validation through coupling at the 4-Bpin site |
Does fluorination affect potency or selectivity? | Can be compared with non-fluorinated pyrazoles and other halogenated pyrazoles in SAR studies |
Does heteroaromatic replacement improve properties? | Can be used as one type of fluorinated heteroaromatic input fragment in a molecular library |
Is late-stage modification feasible? | Suitable for coupling-based incorporation into complex core scaffolds |
5. Application Logic of Fluorinated Pyrazole–Bpin from the Perspective of CDK2 Inhibitors
5.1 Why CDK2 Inhibitor Development Requires Fine Structural Optimization
CDK2 is the abbreviation for cyclin-dependent kinase 2. The CDK2-Cyclin E complex is mainly involved in the G1/S transition and S-phase entry, while the CDK2-Cyclin A complex participates in S-phase progression and DNA replication-related regulation. Because abnormal CDK2 activity is associated with the proliferation of certain tumor cells, Cyclin E abnormalities, and resistance to CDK4/6 inhibitors, selective CDK2 inhibitors represent an important direction in anticancer drug discovery.
The challenge in designing CDK2 inhibitors is not merely to obtain enzymatic inhibitory activity, but to achieve a balance among potency, selectivity, and molecular properties. Most CDK inhibitors need to interact with the ATP-binding pocket, while the ATP-binding regions of CDK family members are highly conserved, which can easily lead to insufficient selectivity among different CDK subtypes. Therefore, molecular optimization often needs to take advantage of subtle differences in the binding pocket. By adjusting heteroaromatic rings, substituents, and connection patterns, researchers can change the hydrogen-bonding pattern, electronic distribution, spatial orientation, and compatibility with solvent-exposed regions.
The value of fluorinated pyrazole–Bpin building blocks lies precisely in this type of structural optimization. The fluorinated pyrazole fragment can serve as a nitrogen- and fluorine-containing heteroaromatic variable for investigating the effects of fluorination and the pyrazole ring on binding mode, selectivity, and physicochemical properties. The Bpin site, meanwhile, provides a connection mode through which the fragment can be incorporated into complex scaffolds via Suzuki-Miyaura coupling. For the design of CDK2 inhibitor analogues, this type of building block provides a structural variable that can be systematically introduced, compared, and optimized.
5.2 Structural Insights from a Patent Route
In the CDK2 inhibitor-related route disclosed in WO2025096061A1, 3-fluoropyrazole-4-boronic ester is used as a coupling fragment in the construction of target compounds. This indicates that fluorinated pyrazole–Bpin structures can be incorporated into the synthetic routes of real drug-like molecules.
From a synthetic-route perspective, the Bpin site is responsible for introducing the 3-fluoropyrazole fragment into complex scaffolds. From a medicinal chemistry perspective, the 3-fluoropyrazole fragment provides structural modulation variables derived from the nitrogen-containing heteroaromatic ring and the fluoro substituent. Together, these two elements allow the building block to serve both synthetic construction and SAR comparison among analogues. When an inhibitor program requires fine tuning in a heteroaromatic region, a coupling-capable fluorinated pyrazole building block can turn a structural concept into synthesizable and comparable candidate molecules.
6. From Structure to Application: R&D Insights Provided by This Building Block
6.1 A Fragment Should Have a Clear Medicinal Chemistry Function
The fluorinated pyrazole fragment contains a heteroaromatic ring, nitrogen atoms, and a fluoro substituent at the same time. It can provide electronic effects, polarity modulation, hydrogen-bonding features, and regulation of local conformational preference. This type of fragment is suitable for molecular regions that require fine optimization.
6.2 A Fragment Should Have a Clear Connection Mode
The Bpin site enables this fragment to be incorporated into complex scaffolds through Suzuki-Miyaura coupling. For drug discovery, the connectability of a fragment determines whether it can truly enter molecular library construction and SAR studies.
6.3 A Fragment Should Support Structural Comparison
A good building block should help researchers reduce irrelevant variables and make the relationship between structural changes and experimental results easier to interpret. 3-Fluoropyrazole-4-boronic ester is suitable for comparison with non-fluorinated pyrazoles, other halogenated pyrazoles, or different heteroaromatic building blocks, thereby helping determine the actual contribution of fluorination and the pyrazole ring to the target molecule.
7. Summary Table of Representative Chemicals Related to Fluorinated Pyrazole + Bpin Molecular Design
Table 1. Pyrazole Boronic Acid and Pyrazole Boronic Acid Pinacol Ester Building Blocks
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Fluorinated pyrazole boronic ester building block | 1983153-03-2 | 3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ≥97% | Introduces a 3-fluoropyrazole fragment; used for the construction of fluorinated heteroaromatic inhibitor analogues, structure-activity relationship studies, and coupling-based expansion of complex scaffolds | |
Basic pyrazole-4-boronic ester building block | 269410-08-4 | Pyrazole-4-boronic acid pinacol ester | ≥98% | Unsubstituted pyrazole-4-boronic ester building block; used for heteroaryl coupling, introduction of pyrazole fragments, and comparative studies of fluorinated substitution | |
N-Boc-protected pyrazole boronic ester building block | 552846-17-0 | 1-(tert-Butoxycarbonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole | ≥98% | N-Boc-protected pyrazole-4-boronic ester; used for coupling of protected pyrazole fragments, subsequent deprotection, and multistep synthetic route design | |
N-Boc-protected pyrazole boronic acid building block | 1188405-87-9 | N-Boc-pyrazole-4-boronic acid, containing variable amounts of anhydride | ≥98% | Protected pyrazole-4-boronic acid; used for coupling reactions, protecting-group control, and synthesis of 1H-pyrazole derivatives | |
N-Isopropyl pyrazole boronic ester building block | 1071496-88-2 | 1-(1-methylethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | ≥97% | N-isopropyl-substituted pyrazole boronic ester; used for introduction of N-alkyl pyrazole fragments, modulation of hydrophobic substitution, and studies of connection-site effects | |
N-Propyl pyrazole boronic ester building block | 827614-69-7 | 1-propyl-1H-pyrazole-4-boronic acid pinacol ester | ≥97% | N-propyl pyrazole-4-boronic ester; used for modulation of N-alkyl chain length, construction of heteroaromatic molecular libraries, and coupling-based expansion | |
N-Ethyl pyrazole boronic ester building block | 847818-70-6 | 1-ethyl-1H-pyrazole-4-boronic acid pinacol ester | ≥97% | N-ethyl pyrazole-4-boronic ester; used for comparison of N-substitution effects, replacement of heteroaromatic fragments, and structural optimization of small-molecule inhibitors | |
N-Methyl pyrazole boronic ester building block | 761446-44-0 | 1-methylpyrazole-4-boronic acid pinacol ester | ≥97% | N-methyl pyrazole-4-boronic ester; used for introduction of N-methylated pyrazole fragments, SAR control studies, and heteroaryl coupling reactions | |
3-Methyl pyrazole boronic ester building block | 936250-20-3 | 3-methyl-1H-pyrazole-4-boronic acid pinacol ester | ≥97% | 3-methyl pyrazole-4-boronic ester; used for comparison of fluoro substitution versus methyl substitution effects, steric-effect studies, and 4-position coupling of pyrazoles | |
N-Methyl pyrazole boronic acid building block | 847818-55-7 | 1-methyl-1H-pyrazole-4-boronic acid, containing variable amounts of anhydride | ≥95% | N-methyl pyrazole-4-boronic acid; used for heteroaryl coupling, construction of N-methyl pyrazole fragments, and comparison between boronic acid and boronic ester systems | |
N-Benzyl pyrazole boronic ester building block | 761446-45-1 | 1-benzyl-1H-pyrazole-4-boronic acid pinacol ester | ≥95% | N-benzyl pyrazole-4-boronic ester; used for N-benzyl protection or hydrophobic substituent introduction, heteroaromatic coupling, and derivative synthesis | |
Basic pyrazole-4-boronic acid building block | 763120-58-7 | 1H-pyrazole-4-boronic acid, containing variable amounts of anhydride | ≥95% | Unprotected pyrazole-4-boronic acid; used for introduction of pyrazole fragments, comparison of boronic acid and boronic ester reactivity, and heteroaryl coupling studies |
Table 2. Fluorinated Pyrazoles and Halogenated Pyrazole Precursors
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Fluorinated iodopyrazole precursor | 2606872-02-8 | 3-fluoro-4-iodo-1H-pyrazole | ≥97% | 3-fluoro-4-iodopyrazole precursor; used for 4-position coupling of fluorinated pyrazoles, development of borylation routes, and synthesis related to core fluorinated pyrazole boronic esters | |
Basic fluorinated pyrazole fragment | 14521-81-4 | 3-fluoro-1H-pyrazole | ≥97% | Basic 3-fluoropyrazole fragment; used for exploration of N-substitution, halogenation, and borylation routes, as well as design of fluorinated heteroaromatic fragments | |
Positional isomer of fluorinated pyrazole | 35277-02-2 | 4-fluoro-1H-pyrazole | ≥97% | 4-fluoropyrazole fragment; used for comparison of fluorine substitution-position effects, studies of heteroaromatic electronic properties, and synthesis of fluorinated pyrazole derivatives | |
Fluorinated bromopyrazole precursor | 1346555-56-3 | 4-bromo-3-fluoro-1H-pyrazole | ≥97% | 4-bromo-3-fluoropyrazole precursor; used for 4-position borylation of 3-fluoropyrazole, coupling reactions, and development of fluorinated pyrazole–Bpin routes | |
4-Position bromopyrazole precursor | 2075-45-8 | 4-bromopyrazole | ≥99% | 4-position halogenated pyrazole precursor; used for 4-position borylation of pyrazoles, heteroaryl coupling, and preparation of 4-substituted pyrazole derivatives | |
4-Position iodopyrazole precursor | 3469-69-0 | 4-iodopyrazole | ≥98% (HPLC) | 4-position iodopyrazole precursor; used for 4-position coupling, borylation reactions, and preparation of pyrazole-4-boronic ester building blocks | |
N-Boc-protected iodopyrazole precursor | 121669-70-3 | tert-butyl 4-iodopyrazole-1-carboxylate | ≥98% | N-Boc-protected 4-iodopyrazole; used for 4-position coupling and borylation of protected pyrazoles, as well as construction of intermediates in multistep routes | |
3-Position iodopyrazole precursor | 4522-35-4 | 3-iodopyrazole | ≥97% (GC) | 3-position iodopyrazole precursor; used for synthesis of 3-substituted pyrazoles, positional-effect comparisons, and heteroaromatic coupling studies | |
N-Boc-protected bromopyrazole precursor | 1150271-23-0 | 1-Boc-4-bromopyrazole | ≥97% | N-Boc-protected 4-bromopyrazole; used for borylation and coupling reactions of protected pyrazoles, as well as construction of 4-substituted pyrazole molecules | |
3-Position bromopyrazole precursor | 14521-80-3 | 3-bromopyrazole | ≥97% | 3-position bromopyrazole precursor; used for synthesis of 3-substituted pyrazole derivatives, positional-isomer controls, and heteroaromatic structural expansion |
Table 3. Borylation Reagents and Application-Case Compounds
Category | CAS No. | Aladdin Cat. No. | Name | Specification or Purity | Product Features and Applications |
Supporting borylation reagent | 73183-34-3 | Bis(pinacolato)diboron | ≥99% | Commonly used borylation reagent; used for converting halogenated pyrazoles into pyrazole boronic acid pinacol esters and supporting route development for fluorinated pyrazole–Bpin building blocks | |
Supporting borylation reagent | 25015-63-8 | Pinacolborane (HBpin) | ≥97% | Reagent related to hydroboration and borylation; used for preparation of organoboron intermediates, exploration of borylation conditions for heteroaromatic rings, and synthesis of boronic ester building blocks | |
Fluorinated pyrazole drug-like reference compound | 3035735-18-0 | JAK2-IN-10 | — | JAK2 V617F inhibitor research compound; used for studies of JAK2 mutation-related signaling pathways, inhibitor activity evaluation, and reference in the design of fluorinated heteroaromatic drug molecules |
Note: The above are representative Aladdin products for scientific research and formulation research. For more information on product specifications, grades, and COA details, please search by “product name / CAS / catalog number” on the Aladdin official website.
For more related articles, see below:
